Geoff Hodge

Geoff Hodge

Company: SOTIO US

Job title: Chief Executive Officer


BOXR: A Platform for Improving T-Cell Performance in the Solid Tumour Microenvironment 1:45 pm

BOXR Bolt-On CHImeric Receptor is a platform to identify novel transgenes that can enhance CAR-T performance in the solid tumour microenvironment BOXR1030 is SOTIO’s first clinical candidate. It is a GPC3-targeted CAR-T enhanced with the mitochondrial enzyme GOT2 which enhances T-cell performance in low glucose and low oxygen in vitro models and stringent xenograft models…Read more

day: Day 2 - Track A - Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.